Overcoming barriers by local drug delivery with liposomes

被引:201
|
作者
Antimisiaris, S. G. [1 ,2 ]
Marazioti, A. [1 ]
Kannavou, M. [1 ,2 ]
Natsaridis, E. [1 ,2 ]
Gkartziou, F. [2 ]
Kogkos, G. [1 ,2 ]
Mourtas, S. [1 ]
机构
[1] Univ Patras, Sch Hlth Sci, Dept Pharm, Lab Pharmaceut Technol, Rion 26504, Greece
[2] Fdn Res & Technol Hellas FORTH ICES, Inst Chem Engn Sci, Rion 26504, Greece
关键词
Liposomes; Drug; Topical routes; Local delivery; Administration; Ocular; Pulmonary; Nasal; Oral; Intratumoral; Vaginal; Vaccine; COVID-19; BLOOD-BRAIN-BARRIER; SURFACE-MODIFIED LIPOSOMES; IN-VITRO CHARACTERIZATION; SUSTAINED-RELEASE; TRANSDERMAL DELIVERY; CATIONIC LIPOSOMES; LOADED LIPOSOMES; OCULAR DELIVERY; DRY POWDER; BIOLOGICAL BARRIERS;
D O I
10.1016/j.addr.2021.01.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Localized or topical administration of drugs may be considered as a potential approach for overcoming the problems caused by the various biological barriers encountered in drug delivery. The combination of using localized administration routes and delivering drugs in nanoparticulate formulations, such as liposomes, may have additional advantages. Such advantages include prolonged retention of high drug loads at the site of action and controlled release of the drug, ensuring prolonged therapeutic effect; decreased potential for side-effects and toxicity (due to the high topical concentrations of drugs); and increased protection of drugs from possible harsh environments at the site of action. The use of targeted liposomal formulations may further potentiate any acquired therapeutic advantages. In this review we present the most advanced cases of localized delivery of liposomal formulations of drugs, which have been investigated pre-clinically and clinically in the last ten years, together with the reported therapeutic advantages, in each case. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页码:53 / 86
页数:34
相关论文
共 50 条
  • [1] Understanding and overcoming biological barriers for drug delivery
    Mitragotri, Samir
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [2] Electromechanical convective drug delivery devices for overcoming diffusion barriers
    Park, Jihoon
    Ghanim, Ramy
    Rahematpura, Adwik
    Gerage, Caroline
    Abramson, Alex
    JOURNAL OF CONTROLLED RELEASE, 2024, 366 : 650 - 667
  • [3] Overcoming Barriers in Glioblastoma-Advances in Drug Delivery Strategies
    ter Linden, Esther
    Abels, Erik R.
    van Solinge, Thomas S.
    Neefjes, Jacques
    Broekman, Marike L. D.
    CELLS, 2024, 13 (12)
  • [4] Overcoming key biological barriers to cancer drug delivery and efficacy
    Kim, Susy M.
    Faix, Peggy H.
    Schnitzer, Jan E.
    JOURNAL OF CONTROLLED RELEASE, 2017, 267 : 15 - 30
  • [5] Principles of nanoparticle design for overcoming biological barriers to drug delivery
    Elvin Blanco
    Haifa Shen
    Mauro Ferrari
    Nature Biotechnology, 2015, 33 : 941 - 951
  • [6] The Role of Carrier Geometry in Overcoming Biological Barriers to Drug Delivery
    Jordan, Carolyn
    Shuvaev, Vladimir V.
    Bailey, Mark
    Muzykantov, Vladimir R.
    Dziubla, Thomas D.
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (09) : 1259 - 1273
  • [7] Principles of nanoparticle design for overcoming biological barriers to drug delivery
    Blanco, Elvin
    Shen, Haifa
    Ferrari, Mauro
    NATURE BIOTECHNOLOGY, 2015, 33 (09) : 941 - 951
  • [8] Overcoming biological barriers by virus-like drug particles for drug delivery
    Chen, Yu-Ling
    Bao, Chun-Jie
    Duan, Jia-Lun
    Xie, Ying
    Lu, Wan-Liang
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 203
  • [9] Overcoming delivery barriers with LNPs
    Satish G. Jadhav
    Steven F. Dowdy
    Nature Materials, 2021, 20 : 575 - 577
  • [10] Overcoming ocular drug delivery barriers through the use of physical forces
    Huang, Di
    Chen, Ying-Shan
    Rupenthal, Ilva D.
    ADVANCED DRUG DELIVERY REVIEWS, 2018, 126 : 96 - 112